Author: News Room

  AUM: $1.55 billion at March 31, 2024 compared to $1.59 billion at December 31, 2023Book Value per share ended the quarter at $42.80 per share vs $42.11 at December 31, 2023 GREENWICH, Conn., May 09, 2024 (GLOBE NEWSWIRE) — Associated Capital Group, Inc. (“AC” or the “Company”), a diversified financial services company, today reported its financial results for the first quarter ended March 31, 2024. Financial Highlights ($ in 000’s except AUM and per share data) (Unaudited) Three Months Ended March 31,   2024  2023 AUM – end of period (in millions) $1,549  $1,799 AUM – average (in millions)  1,556   1,841          Revenues  3,011   2,465 Operating loss before management fee (Non-GAAP)  (2,988)  (2,590)Investment and other non-operating income/(loss), net  22,625   24,735 Income/(loss) before income taxes  17,655   19,602          Net income/(loss)  13,821   17,754 Net income/(loss) per share-diluted  0.64   0.81          Class…

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 09, 2024 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce the release of financial results for the quarter ended March 31, 2024. All amounts are in United States dollars unless otherwise specified. Nova Leap Q1 2024 Financial Results Financial results for the first quarter ended March 31, 2024 include the following: Q1 2024 revenues of $6,429,721 decreased by 1.9% relative to Q4 2023 revenues of $6,551,865…

On track to read out multiple Phase 2 clinical trials in the coming quarters, beginning in Q3 2024Performance benchmarking completed on BioHive-2, Recursion’s next generation supercomputer, which will support the construction of foundation models across biology, chemistry, and patient outcomesTranscriptomics technology has continued to be scaled to more than 1 million transcriptomes with a whole-genome knockout transcriptomics map to be completed in the coming quartersEntered into a multi-year agreement with Helix to access hundreds of thousands of de-identified records for training causal AI models and designing biomarker and patient stratification strategies SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) –…

– Adds $9-$10 million in Annual Revenue with Positive Net Income Contribution – – Acquisition more than Doubles Backlog to over $210 million – – Expands U.S. Footprint and Product Offering – SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the closing of its acquisition of a 60% majority equity interest in the Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC, both Rhode Island limited…

Q1 revenue up 73% year-on-year, driven by continued GaN adoption in mobile fast chargers and AI-based data centers, and SiC sales in EV, solar and industrial applications.New GaNSlim™ technology expected to advance GaN-based systems’ integration, ease-of-use, time-to-market, and manufacturability, which enable lower system costs compared to silicon-based solutions.   TORRANCE, Calif., May 09, 2024 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation power semiconductors, today announced unaudited financial results for the first quarter ended March 31, 2024. “I am very pleased with our first quarter revenue growth of over 70% from the prior year, despite an overall…

SAN ANTONIO, May 09, 2024 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors from gold mining to airlines, today reported operating revenues of $2.6 million in the quarter ended March 31, 2024. Net income was mostly flat as the Company saw a decrease in advisory fees, lower investment income and lower assets under management (AUM) compared to the previous quarter and the same quarter a year earlier. For the three-month period ended March 31, 2024, average AUM was $1.8 billion, while AUM as…

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) — At the end of the settlement date of April 30, 2024, short interest in 3,072 Nasdaq Global MarketSM securities totaled 11,683,381,571 shares compared with 11,407,213,969 shares in 3,081 Global Market issues reported for the prior settlement date of April 15, 2024. The end of April short interest represent 3.29 days average daily Nasdaq Global Market share volume for the reporting period, compared with 3.20 days for the prior reporting period. Short interest in 1,721 securities on The Nasdaq Capital MarketSM totaled 1,972,635,923 shares at the end of the settlement date of April…

SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2024. “For the first quarter of 2024, I am pleased by our strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, with these results beating the mid-point of our quarterly guidance on each metric. This financial performance demonstrates our ability to continue to scale our business as we drive toward our long-term profitability goals. We are…

New York, NY, May 09, 2024 (GLOBE NEWSWIRE) — In a landmark transaction that has sparked interest across the real estate industry coast to coast, a sprawling Hollywood Hills estate, complete with a pickleball court, media room, bar, gym, two pools, and a spa has been sold for a staggering $62.8 million, marking one of the largest home sales in Los Angeles this year. The sale, finalized by an undisclosed international buyer, underscores the enduring allure of Los Angeles luxury properties and highlights the city’s status as a global hub for high-end real estate investment. Custom staging by New York…

SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons who purchased or otherwise acquired Anavex Life Sciences Corporation (NASDAQ: AVXL) stock between June 21, 2021 and January 1, 2024. Anavex investigates, manufactures, and markets pharmaceuticals for central nervous system (CNS) disorders. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating the Allegations that Anavex Life Sciences Corporation (AVXL) Misled Investors Regarding the Likelihood of Success of its Clinical Trial According…